IPO Financial News

IPOs) are lined up to raise nearly ₹8,000 crore in August, according to investment bankers.Companies such as SBFC Finance, Concord Biotech, Jupiter LifeLine Hospitals, TVS Supply Chain Solutions, Balaji Speciality Chemicals, Yatra Online, Innova Captab, Aeroflex Industries, Rishabh Instruments, and Vishnu Prakash R Punglia are likely to launch their maiden public issue this month. The ₹1,551 crore public issue of Ahmedabad-based pharmaceutical firm Concord Biotech will open today for public subscription, while the ₹1,025 crore Mumbai-based non-banking finance company SBFC Finance public issue opened on Wednesday. The mood in the primary market is better now with a strong secondary market, according to bankers.

Concord Biotech IPO: Rare Enterprises-backed Concord Biotech said in an exchange filing that it has raised ₹465 crore from anchor investors, a day ahead of its initial public offer (IPO) opening for bidding. Concord Biotech IPO will open for subscription on Friday, August 4 and close on Tuesday, August 8. The company had fixed the price band at ₹705 to ₹741 per equity share for the proposed initial public offer.

IPO papers with Sebi in December 2022 The IPO of Indegene consists of a fresh issue of equity shares worth up to Rs 950 crore and offer for sale (OFS) of up to 3.63 crore equity shares by existing investors, according to the Draft Red Herring Prospectus (DRHP). The OFS consists of up to 27 lakh equity shares to be sold by individual selling shareholders — Manish Gupta, Rajesh Bhaskaran Nair, and Anita Nair — and up to 3.36 crore equity shares by existing investors, including Carlyle, Brighton Park Capital and the Nadathur Family Office.

Also Read: Zeal Global Services IPO: Subscription status on day 3, and other key details here If you have applied for the Zeal Global IPO , you can check your Zeal Global IPO allotment status immediately on the website of the IPO registrar, Skyline Financial Services Private Ltd. You can check the Zeal Global IPO allotment status of your application on this link - https://www.skylinerta.com/ipo.php Visit the above link which will take you to Zeal Global IPO's registrar's website i.e Skyline Financial Services Private Ltd. Choose the IPO in the dropbox that will only have its name set in if the allocation is completed.

₹400 crore and an offer for sale (OFS) of up to 4,68,19,635 shares by promoters and existing shareholders. The shareholders in the OFS would include promoters and co-founders -- Varun Alagh and Ghazal Alagh -- Bollywood actor Shilpa Shetty Kundra, Rohit Kumar Bansal, Sofina Ventures and Kunal Bahl. According to the Draft Red Herring Prospectus (DRHP), the IPO of Indegene comprises of a fresh issue of equity shares worth up to ₹950 crore and OFS of up to 3.63 crore equity shares by existing investors.

IPO) of Concord Biotech will open for public subscription on August 4 and close on August8. Ahead of the issue opening, the company's shares commanded a premium of Rs Rs 325 in the unlisted market. The company is one of the leading global manufacturers of select fermentation-based APIs (F-APIs) across immunosuppressants and oncology with market share of over 20% by volume in 2022.

offer for sale (OFS) component. The offer also entails a subscription reservation by eligible employees. A total of ₹58.64 crore of the proceeds from its fresh issue would be utilised for capital equipment purchases, while ₹140 crore will be allocated to the company's working capital needs and other corporate purposes.

Honasa Consumer and Indegene filed their preliminary IPO papers with Sebi in December 2022, while that of Vishnu Prakash R Punglia was filed in April 2023. The three companies obtained Sebi's observations letter during July 25-28, an update with the regulator showed on Thursday.

small and medium enterprises (SME). The IPO will remain open for public subscription till August 8. Check out key things to know about Sangani Hospitals IPO: Sangani Hospitals IPO Dates: Sangani Hospitals IPO opens for subscription on Friday, August 4, and will close on August 8, Tuesday.

₹115 to ₹118 per equity share for the proposed SME initial public offer. Oriana Power IPO lot size consists of 1200 equity shares and the multiples of 1200 equity shares thereafter. Oriana Power IPO is made up of a completely fresh equity offering of up to 50.5 lakh equity shares totalling up to ₹59.6 crore.

IPO subscription status: SBFC Finance IPO was subscribed 1.11 times on day 1 so far. SBFC Finance IPO opened today and will close on Monday, August 7.

₹50 per equity share. The public issue opened on Tuesday, July 25 and closed on Thursday, July 27. Innovatus Entertainment Networks IPO subscription status was 105.21 times on day 3.

DoorDash raised its annual core profit forecast for a second time and posted an upbeat quarterly revenue as groceries and food orders jumped, sending its shares up more than 4% after the bell on Wednesday. The delivery firm posted its highest revenue since its IPO in Dec. 2020 as people stick to the pandemic trend of buying from their homes, thanks to promotions, deals and free deliveries with subscription passes by DoorDash and its rivals.

Also Read: SBFC Finance IPO: GMP, subscription status, should you apply or not? Shri Techtex IPO plans to raise ₹45-50 crore. The company plans to use the net proceeds from the offering to pay for the following projects, including building a factory shed, starting a solar farm, buying equipment, meeting working capital needs, serving general corporate objectives, and covering public offering costs.

Yudiz Solutions IPO: The initial public offering (IPO) of the Yudiz Solutions is going to hit primary markets on 4th August 2023 i.e. today. The public issue will remain open fir bidding till 8th August 2023.

Yatharth Hospital IPO: After finalisation of share allotment on Wednesday, investors would be busy checking Yatharth Hospital IPO allotment status. For their information, they can do it online in two ways — first by logging in at the BSE website or at the website of its official registrar Link Intime India Private Limited. However, for convenience, they can do it with more ease by logging in at the direct BSE link — bseindia.com/investors/appli_check.aspx or at direct Link Intime web portal — linkintime.co.in/mipo/ipoallotment.html.

₹1,890 apiece on BSE, and Mankind Pharma stock price was hovering near its 52-week high level. Mankind pharma Q1 results posted record quarter in all aspects. Revenues grew 18% year-on-year to ₹2,579 crore, whereas its EBITDA grew 43% to ₹660 crore (EBITDA margins expanded 450 bps to 25.6%).

Analysts have given a mixed verdict, staying cautious on IPO with probable pressure on margins, profitability and rising risk of defaults. At the upper price band of Rs 57 per share, the stock is valued at 3x P/BV trailing FY23 book. «Considering the subdued ROE profile of the company as well as high post-issue adequacy of 50%, return ratios are expected to remain under pressure in coming years.

“There is enormous opportunity arising in Defense, semiconductor manufacturing, EV, Renewables and contract manufacturing and a lot of small to medium companies have started to operate in these areas, and these companies could well be future candidates for IPOs,” says Roop Bhootra, CEO, Investment Services, Anand Rathi Shares and Stock Brokers. In an interview with ETMarkets, Bhootra, said: “Investors should always deeply study the companies and the valuation it is demanding before applying in new IPOs” Edited excerpts:We are seeing some nervousness at record highs for Mr. Market. How do you see things moving – have we hit the top for the moment? We are in the middle of the earnings season and about 30 out of 50 companies have declared earnings so far, and in index weight terms, it is about 70%.

₹304.4 crore from anchor investors, a day ahead of its IPO subscription opening for bidding. SBFC Finance's initial public offering (IPO) will open for subscription on Thursday, August 3 The public issue with a face value of ₹10 per equity share comprises of up to ₹600 crore of fresh issue and an offer for sale of up to ₹425 crore.

Aeroflex Industries has received approval from the market regulator for its Rs 350 crore Initial Public Offering (IPO). The company has secured a final observation from the Securities and Exchange Board of India (Sebi), which equates to approval. Aeroflex filed its preliminary IPO papers with the regulator in March of this year.